ããšæãïŒãã€ãã£ïŒæ±ºæžå¯èœã»ãã€ã§ããã£ã³ã»ã«OKïœãã³ãžã£ã 2.5mg~12.5mg
ãPaidy察å¿ããã³ãžã£ã 2.5mgã12.5mgïœ3ã¶æãŸãšãè²·ããã©ã³
ä»ããå§ããŠããæ¯æãã¯ããšãã
PaidyïŒãã€ãã£ïŒãªããã¯ã¬ãžããã«ãŒãäžèŠã§ãã³ãžã£ãæ²»çãå§ããããŸãã
â
ã¡ãŒã«ã¢ãã¬ã¹ãšæºåž¯çªå·ã ãã§å©çšå¯èœ
â
ã¯ã¬ãžããã«ãŒãäžèŠ
â
åå²ææ°æã»éå©0å*
â
æã
ã®è² æ
ãæããŠã¹ã¿ãŒã
ãã©ã³å 容
ãã³ãžã£ã 2.5mgã12.5mg
3ã¶æãŸãšãè²·ããã©ã³ïŒLuxora PassïŒ
å»åž«ã«ãããªã³ã©ã€ã³èšºçåŸãåŠæ¹ãé©åãšå€æãããå Žåã«ãè¬ããèªå® ãžãå±ãããŸãã
â
ãã€ã§ã倿Žã»ãã£ã³ã»ã«å¯èœ
â
ãªã³ã©ã€ã³èšºçã®ã¿ïŒæ¥é¢äžèŠïŒ
â
åŠæ¹ãããªãã£ãå Žåã¯å
šé¡è¿é
ãã³ãžã£ããšã¯ïŒ
äžçåã®æç¶æ§GIP/GLP-1å容äœäœåè¬ã§ãåœå ã諞å€åœã§2åç³å°¿ç æ²»çè¬ãšããŠæ¿èªãããŠãããè¬ã§ãã

äž»ãªç¹åŸŽ
Â
- é±ïŒåã®ç°¡åãªèªå·±æ³šå°
- 飿¬²ãæããæºè ¹æãæç¶ããã
- è¡ç³å€ãã³ã³ãããŒã«

æç𿹿³ã«ã€ããŠ
é±1åã®ç®äžæ³šå°ã§äœ¿çšããè¬å€ã§ããæ³šå°ãšèããšæµæãæããæ¹ãããã£ããããããããŸãããããã³ãžã£ãã¯å°çšã®æ³šå ¥åšãã¢ããªã¹ãã䜿çšãããããæ¯èŒçç°¡åã«æ³šå°ããããšãã§ããŸãã
ã䜿çšã®æµãã
- æºåïŒæ³šå°ããéšäœãæž æœã«ããŸãã
- éã®åãä»ã確èªïŒéããã£ãããšåãä»ããããŠããã確èªããŸãã
- 泚å°ãå®äºãããšãã«ãããšããé³ã2å鳎ããŸãã
äž»ãªå¯äœçš
åãæ°ãèžãããäœè¡ç³ã䟿ç§ãäžç¢ãªã©
åãæ°ãèžããçãåããããGLP-1å¯äœçšè»œæžã»ããã販売ããŠãããŸãã®ã§ããåžæã®æ¹ã¯èšºå¯æãç³ãåºãã ããã
å»è¬åæ å ±ããŒãž 
Â
ð± ãè¬ã®åãåãæ¹æ³
ããå©çšã®æµãã æ¬ãã©ã³ã«ãç³ã蟌ã¿ããã ããšããç»é²ã®ã¡ãŒã«ã¢ãã¬ã¹ã«ãªã³ã©ã€ã³èšºçã®ãæ¡å ãšãèšºå¯æã«é©çšãããå²åŒæ å ±ïŒããã¢ã³ãŒãïŒãéä»ãããŸãããã®å²åŒæ å ±ïŒããã¢ã³ãŒãïŒããªã³ã©ã€ã³èšºçå蚺æã«ãå©çšãã ãããå»åž«ã®èšºå¯ã»åŠæ¹ãçµãŠããè¬ããèªå® ã«çºéãããŸãã
STEP 1ïŒãã®ããŒãžã§ãã³ãžã£ãæ²»çã®ã¯ãŒãã³ããè³Œå ¥ãã ããã
STEP 2ïŒãç»é²ã®ã¡ãŒã«ã¢ãã¬ã¹ã«ãªã³ã©ã€ã³èšºçã®æ¡å ãšãã¯ãŒãã³ãå±ããŸãã
STEP 3ïŒã¡ãŒã«å ã®ãªã³ã¯ãã¯ãªãã¯ããŠãelifeã®ãŠã§ããµã€ãããç¡æã®å»åž«ã«ãŠã³ã»ãªã³ã°ããäºçŽãã ãããïŒâ»elifeãžã®ãç»é²ã¯ãå¿ ãã¯ãŒãã³ãåãåã£ãã¡ãŒã«ã¢ãã¬ã¹ãã䜿çšãã ãããïŒ
STEP 4ïŒå»åž«ãšã®èšºå¯åŸãåŠæ¹ãããããšãå®éã®ååããèªå® ã«çºéãããŸããïŒâ»å蚺祚ã®çµæãå»åž«ã®å€æã«ãããåŠæ¹ãããªãå ŽåããããŸãããã®éã¯å šé¡è¿éããããŸããïŒ
â»æ¬èšºçã¯èªè²»èšºçã§ãã
ð 詳ããæ å ±ã¯ [ãå©ç𿹿³ããŒãž] ãã芧ãã ãã
ç§ãã¡ã¯ãåã«è¬ãåŠæ¹ããã ãã§ã¯ãããŸããããªã³ã©ã€ã³èšºçãéããŠãå»åž«ãããªãã®å¥åº·ç¶æ ããã£ãããšç¢ºèªããå®å šãªæ²»çããµããŒãããŸãã
âïž å»åž«ã«ããäžå¯§ãªãªã³ã©ã€ã³èšºçïŒçžè«ã»èšºå¯æã¯ç¡æïŒ ããªãã®å¥åº·ç¶æ ããäžå®ãªç¹ããã£ãããšãã¢ãªã³ã°ããå蚺祚ã®å 容ãšåãããŠå»åž«ãç·åçã«åŠæ¹ã®å¯åŠã倿ããŸããç§ãã¡ã¯ãæ£è æ§ã®å®å šã確èªãããå Žåã«ã®ã¿ãè¬ãåŠæ¹ããŸããäžãäžãåŠæ¹ãèŠéãããå Žåã§ãè²»çšã¯äžåããããŸããã®ã§ããŸãã¯ãæ°è»œã«ãçžè«ãã ããã
âïž èšºå¯ãããè¬ãŸã§ããã¹ãŠã¹ããã§å®çµ äºçŽãã蚺å¯ããè¬ã®åãåããŸã§ããã¹ãŠãããªãã®ã¹ããŒããã©ã³äžã§å®çµããŸããã¯ãªããã¯ã«è¶³ãéã¶å¿ èŠã¯ãªãããèªå® ã奜ããªå Žæããå蚺ãå¯èœããè¬ã¯æçã§ç¿æ¥ã«çºéãããããªãã®ç掻ãªãºã ã厩ããã«æ²»çãç¶ããããŸãã
âïž ãã€ãªã³ã¬ã«å»åž«ã«ãããèšèªã®å£ãè¶ãããµããŒã elifeã«ã¯ãæ¥æ¬èªãšè±èªã®äž¡æ¹ã«å¯Ÿå¿å¯èœãªå»åž«ãåšç±ããŠããŸããèšèªã«äžå®ã®ããæ¹ã§ãããåžæã®èšèªã§å®å¿ããŠãçžè«ã»ãå蚺ããã ããŸãã
âïž æ²»çäžãå®å¿ã®ç¶ç¶ãµããŒãäœå¶ ãè¬ãåŠæ¹ããŠçµããã§ã¯ãããŸãããæ²»çäžã®ãäžå®ãªç¹ã¯å»åž«ã«ããæç¶ãã«é¢ãããäžæç¹ã¯åœé¢ã®ã«ã¹ã¿ããŒãµããŒãã«ããã€ã§ããçžè«ããã ããŸãã
âïž ãã©ã€ãã·ãŒãžã®åŸ¹åºé æ ® ãªã³ã©ã€ã³èšºçãªã®ã§ã誰ã«ãäŒããã«èšºå¯ãããè¬ã®åãåããŸã§ãå¯èœã§ãããå±ããããè¬ã¯ããã©ã€ãã·ãŒã«é æ ®ããã·ã³ãã«ãªæ¢±å ã§ããå®¶æã«ãäžèº«ãåãããªãããã«ãå±ãããŸãã
ð§ ãäžæç¹ãããã°ãelifeã«ã¹ã¿ããŒãµããŒããŸã§ãæ°è»œã«ãåãåãããã ããã
ããããã質å
åé¡ã解決ããªãå Žåã¯LINEã§ãåãåãããã ããã¡ã«ãã¬ã«ãç»é²äžããã
Luxoraã®ãåŸãªæ å ±ãçºä¿¡ããŠããŸãã